ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Friedrich W. Mohr
Thomas Walther
Volkmar Falk
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mohr, F. W.
Right arrow Articles by Dalichau, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mohr, F. W.
Right arrow Articles by Dalichau, H.

Ann Thorac Surg 1995;60:171-175
© 1995 The Society of Thoracic Surgeons

The Toronto SPV Bioprosthesis: One-Year Results in 100 Patients

Friedrich W. Mohr, MD, Thomas Walther, MD, Mersa Baryalei, MD, Volkmar Falk, MD, Rüdiger Autschbach, MD, Albert Scheidt, MD, Harald Dalichau, MD

Department of Thoracic and Cardiovascular Surgery, Georg-August-University Göttingen, Göttingen, Germany

Accepted for publication March 23, 1995.

Background. We studied the long-term results of heart valve replacement with the Toronto SPV bioprosthesis.

Methods. From March 1993 until July 1994 the Toronto stentless bioprosthesis was implanted in 100 selected patients with a mean age of 70.7 years. The predominant aortic valve lesion was stenosis in 94 and insufficiency in 6 cases. Eighty-eight patients received a valve 25 mm in diameter or larger. Additional coronary artery bypass grafting was performed in 37 cases. Hospital mortality was 4%. Seventy-four patients were seen at 6 months and 38 patients at 1 year follow-up.

Results. Structural deterioration, thromboembolism or hemorrhage were not encountered. Nonstructural dysfunction lead to reoperation in 1 patient. Another patient presented with endocarditis at 1 year postoperatively. There were no other valve-related complications. Echocardiographic mean pressure gradients ranged from 7.7 to 11.1 mm Hg postoperatively. There was a significant decrease in pressure gradients at 6 months of follow-up. Minimal aortic valve incompetence was seen in 3 patients.

Conclusions. The Toronto stentless bioprosthesis has superior hemodynamics and is an excellent alternative to conventional stented bioprostheses. Long-term evaluation has to prove whether this promising new valve can live up to its expectations.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
S. Lehmann, T. Walther, S. Leontyev, J. Kempfert, J. Garbade, M. A. Borger, and F. W. Mohr
The Toronto Root Bioprosthesis: Midterm Results in 186 Patients.
Ann. Thorac. Surg., June 1, 2009; 87(6): 1751 - 1756.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. Lehmann, T. Walther, J. Kempfert, S. Leontjev, A. Rastan, V. Falk, and F. W. Mohr
Stentless Versus Conventional Xenograft Aortic Valve Replacement: Midterm Results of a Prospectively Randomized Trial
Ann. Thorac. Surg., August 1, 2007; 84(2): 467 - 472.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. B. Chambers, H. M. Rimington, F. Hodson, R. Rajani, and C. I. Blauth
The subcoronary Toronto stentless versus supra-annular Perimount stented replacement aortic valve: Early clinical and hemodynamic results of a randomized comparison in 160 patients
J. Thorac. Cardiovasc. Surg., April 1, 2006; 131(4): 878 - 882.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
M. Tamim, T. Bove, Y. Van Belleghem, K. Francois, Y. Taeymans, and G. J Van Nooten
Stentless vs. Stented Aortic Valve Replacement: Left Ventricular Mass Regression
Asian Cardiovasc Thorac Ann, June 1, 2005; 13(2): 112 - 118.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
W. B. Eichinger, F. Botzenhardt, R. Gunzinger, B. M. Kemkes, A. Sosnowski, D. Maiza, E. O. Coto, and N. Bleese
European experience with the Mosaic bioprosthesis
J. Thorac. Cardiovasc. Surg., August 1, 2002; 124(2): 333 - 339.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. Pibarot and J. G. Dumesnil
Hemodynamic and clinical impact of prosthesis-patient mismatch in the aortic valve position and its prevention
J. Am. Coll. Cardiol., October 1, 2000; 36(4): 1131 - 1141.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Walther, V. Falk, G. Langebartels, M. Kruger, U. Bernhardt, A. Diegeler, J. Gummert, R. Autschbach, and F. W. Mohr
Prospectively Randomized Evaluation of Stentless Versus Conventional Biological Aortic Valves : Impact on Early Regression of Left Ventricular Hypertrophy
Circulation, November 9, 1999; 100 (2009): II-6 - II-10.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. L. Yun, C. F. Sintek, A. D. Fletcher, T. A. Pfeffer, G. S. Kochamba, M. R. Hyde, J. O. Torpoco, and S. Khonsari
Aortic Valve Replacement With the Freestyle Stentless Bioprosthesis : Five-Year Experience
Circulation, November 9, 1999; 100 (2009): II-17 - II-23.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. Furukawa, H. Ohteki, Z.-L. Cao, K. Doi, Y. Narita, N. Minato, and T. Itoh
Does dilatation of the sinotubular junction cause aortic regurgitation?
Ann. Thorac. Surg., September 1, 1999; 68(3): 949 - 953.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. A. M. van Son, R. Battellini, M. Mierzwa, T. Walther, R. Autschbach, and F. W. Mohr
AORTIC ROOT RECONSTRUCTION WITH PRESERVATION OF NATIVE AORTIC VALVE AND SINUSES IN AORTIC ROOT DILATATION WITH AORTIC REGURGITATION
J. Thorac. Cardiovasc. Surg., June 1, 1999; 117(6): 1151 - 1155.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
P. Bertolini, G. B. Luciani, B. Vecchi, P. Pugliese, and A. Mazzucco
Aortic valve replacement with the biocor PSB stentless xenograft
Ann. Thorac. Surg., August 1, 1998; 66(2): 425 - 430.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
G. Bhatnagar, G. T. Christakis, P. M. Murphy, D. Oxorn, and B. S. Goldman
Technique for Reconstruction of the Sinotubular Junction
Ann. Thorac. Surg., February 1, 1997; 63(2): 559 - 560.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
D. F. Del Rizzo, B. S. Goldman, G. T. Christakis, and T. E. David
HEMODYNAMIC BENEFITS OF THE TORONTO STENTLESS VALVE
J. Thorac. Cardiovasc. Surg., December 1, 1996; 112(6): 1431 - 1446.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
X. Y. Jin, Z.-M. Zhang, D. G. Gibson, M. H. Yacoub, and J. R. Pepper
Effects of Valve Substitute on Changes in Left Ventricular Function and Hypertrophy After Aortic Valve Replacement
Ann. Thorac. Surg., September 1, 1996; 62(3): 683 - 690.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1995 by The Society of Thoracic Surgeons.